» Articles » PMID: 22291192

Leptospiral Immunoglobulin-like Proteins Interact with Human Complement Regulators Factor H, FHL-1, FHR-1, and C4BP

Overview
Journal J Infect Dis
Date 2012 Feb 1
PMID 22291192
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Leptospira, the causative agent of leptospirosis, interacts with several host molecules, including extracellular matrix components, coagulation cascade proteins, and human complement regulators. Here we demonstrate that acquisition of factor H (FH) on the Leptospira surface is crucial for bacterial survival in the serum and that these spirochetes, besides interacting with FH, FH related-1, and C4b binding protein (C4BP), also acquire FH like-1 from human serum. We also demonstrate that binding to these complement regulators is mediated by leptospiral immunoglobulin-like (Lig) proteins, previously shown to interact with fibronectin, laminin, collagen, elastin, tropoelastin, and fibrinogen. Factor H binds to Lig proteins via short consensus repeat domains 5 and 20. Competition assays suggest that FH and C4BP have distinct binding sites on Lig proteins. Moreover, FH and C4BP bound to immobilized Ligs display cofactor activity, mediating C3b and C4b degradation by factor I. In conclusion, Lig proteins are multifunctional molecules, contributing to leptospiral adhesion and immune evasion.

Citing Articles

Serine protease RAYM_01812 (SspA) inhibits complement-mediated killing and monocyte chemotaxis and contributes to virulence of in ducks.

Yang R, Li S, Guo J, Wang Y, Dong Z, Wang Q Virulence. 2024; 15(1):2421219.

PMID: 39450484 PMC: 11540087. DOI: 10.1080/21505594.2024.2421219.


Unveiling the impact of TolC efflux protein on host tissue adherence, complement evasion, and diagnostic potential.

Hota S, Kumar M Infect Immun. 2024; 92(11):e0041924.

PMID: 39392312 PMC: 11556070. DOI: 10.1128/iai.00419-24.


Leptospiral adhesins: from identification to future perspectives.

Surdel M, Coburn J Front Microbiol. 2024; 15:1458655.

PMID: 39206373 PMC: 11350617. DOI: 10.3389/fmicb.2024.1458655.


Current treatment options for leptospirosis: a mini-review.

Petakh P, Behzadi P, Oksenych V, Kamyshnyi O Front Microbiol. 2024; 15:1403765.

PMID: 38725681 PMC: 11081000. DOI: 10.3389/fmicb.2024.1403765.


Evaluation of knockdown mutants for LipL32, LipL41, LipL21, and OmpL1 proteins.

Fernandes L, Teixeira A, Nascimento A Front Microbiol. 2023; 14:1199660.

PMID: 37426019 PMC: 10326724. DOI: 10.3389/fmicb.2023.1199660.